A new Phase 2 clinical study is now enrolling adults with moderate to severe asthma to evaluate the safety and efficacy of Brenipatide, an investigational, once-weekly subcutaneous injection designed ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Patients either continued to receive depemokimab or ...

Among children, adolescents and adults with peanut allergy, a once-daily peanut sublingual immunotherapy tablet was well tolerated up to the highest dose in an up-dosing regimen, according to phase ...

Women experience more frequent asthma attacks, and prior attack history is a statistically stronger predictor of future events in men.

An asthma medication improves asthma control, respiratory quality of life, and upper airway symptoms in patients with chronic ...

AROUND 2 MILLION PEOPLE IN THE U.S. ARE LIVING WITH SEVERE ASTHMA.WITH THE SEASON CHANGING AND DIFFERENT WEATHER PATTERNS ON ...

Warmer temperatures will cause an early, strong season with high tree pollen levels moving north from the South and Ohio ...

Generate Biomedicines IPO highlights AI-driven drug discovery, strong backing, promising pipeline, and investor confidence signals.

The 29-year-old woman who died in a Bloomington police holding cell has been identified by her family. Desiree Marie Rosell ...

Mackenzie Sinclair was walking through a bustling Melbourne Central last spring when she realised she could no longer breathe ...

Our Clean Air School Challenge empowers K-12 schools nationwide to create healthier learning environments and improve child health.

Is it possible to train the body to resist seasonal allergies? That’s the hope promised by a new line of immunotherapy ...